Patent · US Expired

Anti-inflammatory peptides derived from IL-2 and analogues thereof

US6906170B1 · kind B1 · utility

10Cited by
0References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 19, 1999
Grant dateJun 14, 2005
Priority date
Expiry dateAug 19, 2019

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Synthetic anti-inflammatory peptides derived from the sequence of IL-2 are provided. Parent peptides of the sequences Ile-Val-Leu, Glu-Phe-Leu-Asn-Arg-Trp-Ile-Thr (SEQ ID NO:1) and Arg-Met-Leu-Thr (SEQ ID NO:2), were obtained by elastase enzymatic digestion of IL-2, synthesized and modified. The peptides are useful in conditions of acute and chronic inflammation such as in autoimmune diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.